Back

Should we address other lipid/lipoproteins besides LDL-C?

27 August 2018 (08:52 - 09:15)
Organised by:
Congress Presentation Part of: Lipid-lowering therapy: how to tailor treatment to your patient Drug therapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Ruth Frikke-Schmidt

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

3 More presentations in this session

Presentation thumbnail
Treatment intensity in primary and secondary prevention? The role of precision medicine.
Professor J. Deanfield (London, GB)
Slides Video
Presentation thumbnail
When should we add PCSK-9 inhibitors?
Professor S. Nicholls (Melbourne, AU)
Slides Video
Presentation thumbnail
Is there a place for anti-inflammatory medication in clinical practice?
Professor K. Ray (London, GB)
Slides Video

Access the full session

Session thumbnail
Lipid-lowering therapy: how to tailor treatment to your patient

The Event

Event poster

ESC Congress 2018

27 August 2018 08:52 CET
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
New trial evidence in the field of lipid management

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources